Skip to product information
1 of 1

SZA LONGEVITY UK

Carrier Screening Test

Carrier Screening Test

Regular price £325.00 GBP
Regular price Sale price £325.00 GBP
Sale Sold out
Taxes included. Shipping calculated at checkout.

Many people carry genetic mutations without showing symptoms. The SZA Longevity Carrier Screening Test identifies whether you carry genes for inherited conditions that could be allowing you to make informed reproductive choices with confidence. If you are a carrier, genetic counselling can help guide your next steps. 

Our comprehensive panel screens for thousands of genetic conditions, including: 

  • Cystic Fibrosis
  • Spinal Muscular Atrophy (SMA)
  • Sickle Cell Anaemia 
  • Tay-Sachs Disease
  • Fragile X Syndrome
  • More than 1,000 genetic conditions
  • Results in 3 weeks
  • Recycleable Packaging
View full details

Why Carrier Screening Matters

1 in 4

Couples Carry the Same Genetic Condition.

+

1

%

of Individuals Are Carriers of At Least One Condition.

~

1

%

of Rare Diseases have a genetic basis - According to UK's Rare Diseases Action Plan.

1 in 100

Couples in the UK are at risk of having a child affected by a serious recessive condition.

This Test is Highly Recommended for

Individuals or couples planning to start a family

People from ethnic backgrounds with a higher risk of specific genetic disorders

Anyone seeking proactive, genetics-based health insights

Those with a family history of inherited genetic conditions

Individuals or couples planning to start a family

People from ethnic backgrounds with a higher risk of specific genetic disorders

Anyone seeking proactive, genetics-based health insights

Those with a family history of inherited genetic conditions

what do we analyse

Scope of Analysis: Carrier Screening Test

Core Gene Panel Coverage: More Than 1000 Conditions Analysed

Analysis of key inherited conditions including cystic fibrosis, spinal muscular atrophy (SMA), Fragile X syndrome, and congenital bilateral absence of the vas deferens (CBAVD).

Expanded Panel Options

Broader screening that includes over 200 additional genes associated with inherited disorders such as cystinosis, Smith-Lemli-Opitz syndrome, Krabbe disease, Zellweger syndrome, and spinal cerebellar ataxias.

Haemoglobinopathies & Blood Disorders

Identification of gene variants linked to beta-thalassemia, alpha-thalassemia, sickle cell anaemia, and glucose-6-phosphate dehydrogenase (G6PD) deficiency.

Neuromuscular & Developmental Disorders

Screening for Duchenne muscular dystrophy, Becker muscular dystrophy, Rett syndrome, ataxia-telangiectasia, and spinal muscular atrophy (SMA).

Reproductive and Fertility-Related Conditions

Screening includes genes associated with infertility, premature ovarian failure, congenital absence of the vas deferens (linked to CFTR variants), and other hereditary reproductive syndromes that may impact family planning.

Lysosomal Storage Disorders

These progressive and often severe diseases (e.g. Gaucher, Niemann-Pick, Tay-Sachs) are frequently included in comprehensive panels due to their impact and carrier frequency.
Screening includes variants linked to lysosomal storage diseases such as Gaucher, Fabry, Niemann-Pick, and Pompe disease, which are often severe and clinically actionable.

Skeletal and Connective Tissue Disorders

Analysis of genes associated with conditions like osteogenesis imperfecta, Ehlers-Danlos syndromes, and various skeletal dysplasias, which are important for assessing potential carrier status in families with unexplained joint, spine, or bone issues.

Hearing and Vision Loss Syndromes

Includes carrier analysis for syndromes such as Usher syndrome, Pendred syndrome, and nonsyndromic forms of sensorineural hearing and vision impairment, many of which may go undetected without genetic screening.

Rare but Severe Syndromes

Identification of rare yet medically significant syndromes that may present early in life or lead to life-threatening outcomes. This includes high-impact variants with clear reproductive implications, such as spinal muscular atrophy (SMA), Fanconi anaemia, Tay-Sachs disease, Hurler syndrome, and Zellweger spectrum disorders. These conditions are highly penetrant and often go undetected without comprehensive carrier screening.

Ethnicity-Specific Conditions*

Inclusion of conditions with higher prevalence in specific populations: Tay-Sachs disease, Canavan disease, Gaucher disease, Bloom syndrome, Niemann-Pick disease type A, familial dysautonomia, Fanconi anaemia (Ashkenazi Jewish); beta-thalassemia (Mediterranean); sickle cell anaemia (African); and G6PD deficiency (Southeast Asian and Middle Eastern).

*Some genetic conditions are more prevalent in specific ethnic populations due to carrier frequency patterns observed in global genomic studies.

X-linked & Recessive Inheritance Mapping

Classification of each condition based on mode of inheritance, including autosomal recessive conditions, autosomal dominant conditions, and X-linked conditions such as ornithine transcarbamylase (OTC) deficiency, hemophilia A and B, and X-linked SCID.

Variant Detection & Classification

Identification of pathogenic, likely pathogenic, and variants of uncertain significance (VUS) using global guidelines and curated variant databases.

Risk Pairing for Partners

Combined carrier risk interpretation when both partners are tested, supporting informed reproductive decisions when both are carriers of the same condition.

What’s Included in Your Carrier Screening Report

Summary of Your Carrier Status

A concise overview indicating whether any carrier variants were identified and their relevance to reproductive risk.

A concise overview indicating whether any carrier variants were identified and their relevance to reproductive risk.

Gene and Variant Details

Specific information about the gene(s) where a variant was found, including the type of mutation and classification (e.g. pathogenic, likely pathogenic).

Specific information about the gene(s) where a variant was found, including the type of mutation and classification (e.g. pathogenic, likely pathogenic).

Condition-Specific Findings

For each condition tested (e.g. cystic fibrosis, SMA, Fragile X), results are presented clearly with inheritance patterns and potential implications.

For each condition tested (e.g. cystic fibrosis, SMA, Fragile X), results are presented clearly with inheritance patterns and potential implications.

Inheritance Pattern Explanation

Each condition includes a visual or written explanation of whether it follows an autosomal recessive, X-linked, or dominant inheritance model.

Each condition includes a visual or written explanation of whether it follows an autosomal recessive, X-linked, or dominant inheritance model.

Ethnicity-Based Risk Context

Interpretation of your results in the context of your reported ethnic background, especially where certain variants are more prevalent.

Interpretation of your results in the context of your reported ethnic background, especially where certain variants are more prevalent.

Partner Screening Recommendations

If you are identified as a carrier, the report will outline whether partner or donor testing is advised.

If you are identified as a carrier, the report will outline whether partner or donor testing is advised.

Residual Risk Explanation

A brief note explaining the remaining chance of being a carrier even if your result is negative, based on current technology limits.

A brief note explaining the remaining chance of being a carrier even if your result is negative, based on current technology limits.

Glossary and Scientific Notes

Definitions and explanations of key genetic terms and variant classifications to help you better understand your results.

Definitions and explanations of key genetic terms and variant classifications to help you better understand your results.

Next Steps and Optional Counselling

Clear guidance on whether further action is recommended, including the option for genetic counselling or clinical consultation.

Clear guidance on whether further action is recommended, including the option for genetic counselling or clinical consultation.

How it Works: Steps After Purchasing

Step 1

Activate Your Kit

Go to www.szaportal.com/activate and register your kit using the unique Kit ID found inside your box. You’ll also be asked a few optional questions about your health history to help personalise your experience.

Step 2

Download the SZA Longevity App

Download the SZA Longevity app and log in with the same email you used during kit registration. This becomes your official account email.

step 3

Sync Your Health Data (optional)

Choose to sync with Apple Health, Google Fit, or Samsung Health to start tracking your health insights in one place.

step 4

Book Your Genetic Counselling Session

If you wish to explore your results with an expert, you can book a genetic counselling session directly in the app.

step 5

Collect and Return Your Sample

Follow the sample collection instructions in the leaflet inside the kit. Once done, seal your sample in the provided bag, place it into the sponge holder, and return it inside the original box using the prepaid return envelope.

How We Keep Your Genetic Data Safe

At SZA Longevity, your privacy is non-negotiable. All personal and genetic data is handled in accordance with the strictest security standards and is fully protected under the EU’s General Data Protection Regulation (GDPR).

We use encrypted systems for data storage and analysis, and no information is ever shared without your explicit consent.

To learn more, view our full Privacy Policy.

Frequently Asked Questions

What is the SZA Longevity Carrier Screening Test?

Our Carrier Screening Test is a comprehensive genetic test that identifies whether you carry genetic variants that could be passed on to your children. While carriers are typically healthy, they can unknowingly pass on serious inherited conditions. This test helps individuals and couples make informed decisions about family planning by identifying their risk for transmitting genetic disorders.

How does the test work?

  1. Collect a saliva sample using the swab in your test kit.
  2. Send your sample back to our certified lab following the detailed instructions.
  3. Our team performs a high-resolution genetic analysis to detect carrier status for hundreds of inherited conditions.
  4. You will receive a personalized report within 2 weeks in the SZA Longevity App. If needed, you can book a consultation with one of our experts for further support and guidance.

Is there an age limit for the carrier screening test kit?

Yes, you must be over 18 for us to process your sample.

Who should take this test?

This test is recommended for:

  • Individuals or couples planning to have children
  • People with a family history of genetic conditions
  • Individuals from populations with higher carrier risk for specific conditions (e.g., Ashkenazi Jews, Mediterranean African, Southeast Asian descent.)

What are the benefits?

  • Gain clarity about your carrier status for hundreds of inherited conditions.
  • Make informed family planning decisions with the help of expert insights.
  • Reduce the risk of passing on serious genetic conditions to future children.
  • Access expert support through optional consultations for understanding and next steps.
  • Feel empowered with personalized, preventative genetic information.

How common are these conditions?

While individual genetic conditions are rare, collectively they are more common than many realise. Around 1 in 30 couples is at increased risk of having a child affected by a genetic condition​.

Will this tell me anything about my own health?

The test is designed to assess reproductive risk. In rare cases, certain gene variants may have implications for your own health, but this is uncommon. Any relevant findings are explained with medical support.

Can I rely on family history instead?

Not entirely. Most people who carry a genetic condition have no family history of it. Genetic screening can reveal hidden risks that family history alone cannot detect.

If I already know a condition runs in my family, should I still do this?

Yes. Even if you're aware of a specific condition, this test can screen for additional inherited conditions you may not know about.

Can I take this alongside other pregnancy tests like NIPT?

Yes. Carrier screening can be done alongside chromosome testing (like NIPT), but they serve different purposes. NIPT looks at chromosome conditions, while carrier screening looks at inherited single-gene variants.

How do I order the test? Do I need a doctor?

The test can be ordered online and completed at home. You don’t need a doctor to access the test, but our medical team is available to support you and involve your healthcare provider if needed.

What happens if my results indicate a higher risk?

SZA Longevity provides tools to help you access and understand personal health data, but we are not a diagnostic entity and do not provide medical advice. If your results suggest a higher genetic risk, we can arrange a consultation with a qualified healthcare professional or genetic counsellor who can guide you through your options and next steps.

How accurate is the test?

Our tests are processed in accredited laboratories using validated methods and high-quality sequencing technology. While no test can guarantee 100% accuracy, the results are reliable for identifying genetic variants associated with carrier status. Any findings should be discussed with a healthcare professional for appropriate interpretation and follow-up.

How will I receive my results?

Once your sample has been processed, your results will be made available through our secure online platform. You’ll receive an email notification when they’re ready. If further support is needed, we can help you arrange a consultation with a qualified professional to review your results in detail.